Related Experiment Videos
Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease
F Laghrissi-Thode1, W R Wagner, B G Pollock
1Department of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, USA.
Insights
Patients with ischemic heart disease (IHD) and depression show increased platelet activation, indicated by higher Platelet Factor 4 (PF4) and beta-thromboglobulin (beta-TG) levels. This suggests a heightened risk of thrombosis in this patient group.
Area of Science:
- Cardiology
- Psychiatry
- Hematology
Background:
- Clinical depression is an independent risk factor for cardiac mortality post-myocardial infarction.
- Mechanisms linking depression and increased cardiac mortality remain unclear.
- Platelet activation and thrombosis are potential contributors to this risk.
Purpose of the Study:
- To investigate if concurrent ischemic heart disease (IHD) and depression lead to abnormal platelet activation.
- To assess platelet activation markers in depressed IHD patients compared to controls and non-depressed IHD patients.
Main Methods:
- Measured plasma levels of Platelet Factor 4 (PF4) and beta-thromboglobulin (beta-TG).
- Compared levels across three groups: young healthy controls, non-depressed IHD patients, and depressed IHD patients.
Main Results:
- Depressed IHD patients exhibited significantly higher mean PF4 and beta-TG plasma levels than controls and non-depressed IHD patients.
- Elevated levels were independent of age, gender, race, aspirin use, or cardiac disease severity.
Conclusions:
- Depression in IHD patients is associated with increased platelet activation.
- This heightened platelet activation may signify an elevated risk of thrombotic complications in these patients.
Abstract:
Clinical depression has recently been recognized as an independent risk factor for cardiac mortality in patients after myocardial infarction. The underlying mechanisms of this increased mortality remain unclear. This study investigated the hypothesis that patients suffering from ischemic heart disease (IHD) and depression concurrently may have abnormal platelet activation resulting in an increased risk of thrombosis. Platelet factor 4 (PF4) and beta-thromboglobulin (beta-TG) were measured in young healthy control subjects, in nondepressed patients with IHD, and in depressed patients with IHD. Mean PF4 and beta-TG plasma levels in the IHD group with depression were found to be significantly higher than those of the control and IHD groups. This increase was not related to age, gender, racial difference, aspirin use, or severity of cardiac disease. This finding suggests that in depressed patients with IHD there is greater platelet activation, and may indicate an increased risk of thrombotic complications.